Search Count: 43
![]() |
Crystal Structure Of Human Ido1 In Complex With Ideg-3
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-12-10 Classification: OXIDOREDUCTASE Ligands: A1JLE, SO4, PG4, PGE, PEG |
![]() |
Crystal Structure Of Human Ido1 In Complex With Ideg-6
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2025-12-10 Classification: OXIDOREDUCTASE Ligands: PEG, A1JLD, DMS |
![]() |
Crystal Structure Of Human Ido1 In Complex With Ideg-7
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-12-10 Classification: OXIDOREDUCTASE Ligands: A1JLB, PEG |
![]() |
Crystal Structure Of Human Ido1 In Complex With Ideg-9
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-12-10 Classification: OXIDOREDUCTASE Ligands: PEG, A1JLA |
![]() |
Crystal Structure Of Human Ido1 In Complex With Ideg-2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2025-10-01 Classification: OXIDOREDUCTASE Ligands: PG4, PGE, DMS, A1IEE |
![]() |
Crystal Structure Of Human Ido1 In Complex With Ideg-1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-10-01 Classification: OXIDOREDUCTASE Ligands: PGE, A1JGL |
![]() |
Human Usp30 Chimera In Complex With Nk036 Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2025-03-19 Classification: HYDROLASE Ligands: A1H8X |
![]() |
Human Usp30 Chimera Bound To Ubiquitin-Pa
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-03-19 Classification: HYDROLASE Ligands: AYE |
![]() |
Structure Of Usp54 In Complex With Lys63-Linked Diubiquitin-Pa
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2024-07-31 Classification: HYDROLASE Ligands: ZN, AYE, CL, NA |
![]() |
Structure Of Human Park7 In Complex With Gk16S
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.53 Å Release Date: 2024-01-31 Classification: HYDROLASE Ligands: 86F |
![]() |
Structure Of Human Park7 In Complex With Gk16R
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2024-01-31 Classification: HYDROLASE Ligands: 8RX |
![]() |
Structure Of Human Uchl1 In Complex With Cg341 Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2024-01-31 Classification: HYDROLASE Ligands: GKO |
![]() |
Structure Of Human Uspl1 In Covalent Complex With Sumo3-2Br Probe
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2023-09-27 Classification: HYDROLASE Ligands: ZN, GOL, OXU, CL, CA |
![]() |
Structure Of Human Uspl1 In Covalent Complex With Deltan-Sumo2/3-Pa Probe
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2023-09-27 Classification: HYDROLASE Ligands: ZN, AYE, CL |
![]() |
Structure Of Usp36 In Complex With Fubi-Pa
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2023-07-12 Classification: HYDROLASE Ligands: ZN, AYE |
![]() |
Structure Of Usp36 In Complex With Ubiquitin-Pa
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-07-12 Classification: HYDROLASE Ligands: ZN, AYE, NA |
![]() |
Structure Of Uchl1 In Complex With Gk13S Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.24 Å Release Date: 2022-09-14 Classification: HYDROLASE Ligands: JMF |
![]() |
Structure Of The Catalytic Domain Of Usp28 (Insertion Deleted)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2019-03-27 Classification: HYDROLASE Ligands: EDO, CL |
![]() |
Structure Of The Catalytic Domain Of Usp28 (Insertion Deleted) Bound To Ubiquitin-Pa
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.64 Å Release Date: 2019-03-27 Classification: HYDROLASE Ligands: EDO |
![]() |
Structure Of Human Usp28
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.79 Å Release Date: 2019-03-27 Classification: HYDROLASE Ligands: SO4 |




















